People living with HIV/AIDS have an elevated risk for suicide. Although HIV+ substance users are at even greater risk, few studies have been conducted to inform comprehensive management of suicide risk in this population.
Project Hope (CTN0049) was a 3-arm randomized controlled trial that tested six months of patient navigation (with and without financial incentives) compared to treatment as usual in HIV+, substance-using hospitalized patients. Project Hope recruited 801 patients from 11 hospitals in the U.S. from 2012-2014. Predictors of two time-varying outcomes were examined over 12 months: 1) any suicidal thoughts (past week); and 2) a composite measure of suicidality measuring the frequency of suicidal thoughts, considering methods for suicide, and making plans for suicide in the past week. Medical, structural, and psychosocial predictors of these outcomes at baseline, six, and 12 months were examined using mixed linear and logistic regression models.
The sample was predominantly Black (78%), middle-aged (Mean = 44.6; SD = 10.0), and male (67%) with a median CD4+ count of 109 cells/mm.3 Approximately 18% of participants reported any suicidal thoughts at baseline. The Figure summarizes the percentage of participants reporting any suicidal thoughts, methods, or plans over the 12-month follow-up. More severe substance (Adjusted Odds Ratio [AOR] = 1.29; 95% CI = 1.07 – 1.55) and alcohol (AOR = 1.26; 95% CI = 1.02 – 1.55) use disorder symptoms were independently associated with greater odds of reporting any suicidal thoughts over 12 months. Hispanic/Latino ethnicity, a CD4+ T-cell count < 200 cells/mm,3 injection drug use (IDU) during the past year, and more severe alcohol and tobacco use disorder symptoms significantly predicted higher suicidality composite scores over 12 months. In contrast, stable housing and greater social support were associated with significantly lower suicidality composite scores over 12 months. There were no intent-to-treat effects of patient navigation (with or without financial incentives) on any suicidal thoughts or suicidality.
Greater severity of alcohol, tobacco, and other substance use disorders as well as recent IDU are key risk factors for suicidality among HIV+ substance users. Findings also underscore the need for comprehensive approaches to address the medical, structural, and psychosocial factors that may modify suicide risk in this population.